Affordable Access

Publisher Website

Immunogenicity assay validation for an HIV vaccine trial: High IFNγ+/IL-2+CD8+T cells background in healthy Thais

Authors
Journal
Vaccine
0264-410X
Publisher
Elsevier
Publication Date
Volume
29
Issue
35
Identifiers
DOI: 10.1016/j.vaccine.2011.06.035
Keywords
  • Ifnγ+/Il-2+T Cells
  • Intracellular Cytokine Staining
  • Validation
  • Phase I Vaccine Trial
  • Thailand

Abstract

Abstract In a vaccine trial, assays for vaccine immunogenicity if performed locally will strengthen local site, can save costs and avoid hurdles associated with specimen transport. Here we report the optimization and validation of an Intracellular Cytokine Staining (ICS) assay which was undertaken in preparation for a phase I HIV vaccine trial conducted in Thailand. Intra-, and inter-operator variability were easily established. However, while attempting to set population cut offs for a positive response we found 4/36 (11%) high background responses of IFNγ + and/or IL-2 + CD8 + T cells (>1%) in normal healthy volunteers. The determinates of these unexpected responses were explored and minimized.

There are no comments yet on this publication. Be the first to share your thoughts.